no image available Dickens & Co. "Fine-Tuning the Combination: Can We Enhance Tolerability of Capecitabine-Docetaxel without Compromising Survival Benefits?" "Unraveling the Balance between Efficacy and Toxity in a Randomized Phase III Trial: A Closer Look at the Numbers" Price: 30.00€